FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3175702912> ?p ?o ?g. }

• W3175702912 endingPage "7" @default.
• W3175702912 startingPage "1" @default.
• W3175702912 abstract "Background: Antiretroviral therapy (ART) has decreased the mortality and morbidity among people living with HIV and AIDS (PLWH). Viral load (VL) has been used by clinicians as primary tool recommended by WHO to monitor patients progress on High Antiretroviral active therapy (HAART). There is a paucity of information on Virological and immunological outcomes of HIV infected drug experience adults’ patients in north central Nigeria. We conducted a tertiary hospital based cross-sectional study at federal medical centre in Nasarawa state between December 2019 to march 2020.Method: A total of 474 HIV positive adult were enrolled using a Systematic random technique. Blood specimen for CD+4 T cells count and viral load determination were obtained and PCR-Real time and Flow-cytometry were used to estimate plasma viral load and CD4+ T cell count respectively. Frequency was used to determine percentage and logistic regression was used to determine the associated factors with Virological suppression and immunology outcome in patients on HAART 95% CI and odd ratio (OR) was used to measure strength of association.Results: From the 474 cohort that were enrolled 34.6% were on WHO baseline clinical stage IIV and 57.8% of cohort were on HAART, started treatment regimen in less than a year with 42.2% diagnosed and confirmed with HIV infection between 1-5years. 57.8% were transferred into the centre as a major reason for enrolment. 57.8% has history of TB treatment in the past while 42.2% of the study participants who were eligible for treatment initiation were determine by CD4+ counts with a median interquartile range of 180 (92-300) cells/mm3. virological suppression (VL level < 1000 copies/ml) was found in 85% (95% CI 77.7, 86.1) of study participants, and it has been associated with CD4 cell count between 250 and 400 cells/mm3 (adjusted odds ratio (AOR) = 2.56; 95% CI 1.14, 5.75) and > 499 cells/mm3 (AOR = 7.71; 95% CI 3.48, 17.09) at VL testing and current age > 40 years old (AOR = 5.40; 95% CI 2.3, 10.01). Similarly, favourable immunological status (≥250 cells/mm3 for male and ≥ 600 cells/mm3 for female) was observed in 52.9% (95% CI 47.4, 58.8) of the study participants. Baseline CD4 cell count of > 200 cells/mm3, age at enrolment of 26 through 40 years old, and urban residency were significantly associated with favourable immunological outcome.Conclusion: Low Immunological recovery among study cohort was observed although viral suppression was shown in majority of the HIV infected adult who are on HAART. Early initiation on HAART should be encouraged in other to achieve immunological recovery and viral suppression in order to achieve the USAIDS- 90-90-90 to end HIV pandemic by 2030." @default.
• W3175702912 created "2021-07-05" @default.
• W3175702912 creator A5009377467 @default.
• W3175702912 creator A5012659561 @default.
• W3175702912 creator A5015199292 @default.
• W3175702912 creator A5045962418 @default.
• W3175702912 creator A5050366578 @default.
• W3175702912 creator A5085908835 @default.
• W3175702912 date "2021-01-01" @default.
• W3175702912 modified "2023-09-24" @default.
• W3175702912 title "Virological and Immunologic Outcome of HIV Infected Drug Experienced Adults in North Central Nigeria" @default.
• W3175702912 doi "https://doi.org/10.37421/2155-6113.2021.12.848" @default.
• W3175702912 hasPublicationYear "2021" @default.
• W3175702912 type Work @default.
• W3175702912 sameAs 3175702912 @default.
• W3175702912 citedByCount "0" @default.
• W3175702912 crossrefType "journal-article" @default.
• W3175702912 hasAuthorship W3175702912A5009377467 @default.
• W3175702912 hasAuthorship W3175702912A5012659561 @default.
• W3175702912 hasAuthorship W3175702912A5015199292 @default.
• W3175702912 hasAuthorship W3175702912A5045962418 @default.
• W3175702912 hasAuthorship W3175702912A5050366578 @default.
• W3175702912 hasAuthorship W3175702912A5085908835 @default.
• W3175702912 hasConcept C126322002 @default.
• W3175702912 hasConcept C142462285 @default.
• W3175702912 hasConcept C151956035 @default.
• W3175702912 hasConcept C201903717 @default.
• W3175702912 hasConcept C203014093 @default.
• W3175702912 hasConcept C2781413609 @default.
• W3175702912 hasConcept C2993143319 @default.
• W3175702912 hasConcept C3013748606 @default.
• W3175702912 hasConcept C71924100 @default.
• W3175702912 hasConcept C72563966 @default.
• W3175702912 hasConceptScore W3175702912C126322002 @default.
• W3175702912 hasConceptScore W3175702912C142462285 @default.
• W3175702912 hasConceptScore W3175702912C151956035 @default.
• W3175702912 hasConceptScore W3175702912C201903717 @default.
• W3175702912 hasConceptScore W3175702912C203014093 @default.
• W3175702912 hasConceptScore W3175702912C2781413609 @default.
• W3175702912 hasConceptScore W3175702912C2993143319 @default.
• W3175702912 hasConceptScore W3175702912C3013748606 @default.
• W3175702912 hasConceptScore W3175702912C71924100 @default.
• W3175702912 hasConceptScore W3175702912C72563966 @default.
• W3175702912 hasIssue "6" @default.
• W3175702912 hasLocation W31757029121 @default.
• W3175702912 hasOpenAccess W3175702912 @default.
• W3175702912 hasPrimaryLocation W31757029121 @default.
• W3175702912 hasRelatedWork W1914004202 @default.
• W3175702912 hasRelatedWork W200654478 @default.
• W3175702912 hasRelatedWork W2042381230 @default.
• W3175702912 hasRelatedWork W2079063281 @default.
• W3175702912 hasRelatedWork W2119124195 @default.
• W3175702912 hasRelatedWork W2173413904 @default.
• W3175702912 hasRelatedWork W2227950588 @default.
• W3175702912 hasRelatedWork W2317083606 @default.
• W3175702912 hasRelatedWork W2348174320 @default.
• W3175702912 hasRelatedWork W2381952053 @default.
• W3175702912 hasRelatedWork W2580168392 @default.
• W3175702912 hasRelatedWork W2760676824 @default.
• W3175702912 hasRelatedWork W2794759257 @default.
• W3175702912 hasRelatedWork W2883653259 @default.
• W3175702912 hasRelatedWork W2991066578 @default.
• W3175702912 hasRelatedWork W3009173066 @default.
• W3175702912 hasRelatedWork W3033983542 @default.
• W3175702912 hasRelatedWork W3081873579 @default.
• W3175702912 hasRelatedWork W3147979076 @default.
• W3175702912 hasRelatedWork W3172537186 @default.
• W3175702912 hasVolume "12" @default.
• W3175702912 isParatext "false" @default.
• W3175702912 isRetracted "false" @default.
• W3175702912 magId "3175702912" @default.
• W3175702912 workType "article" @default.